Reduced-intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed non-Hodgkin and Hodgkin's lymphomas

被引：0

作者：

Corradini, P

Dodero, A

Bregni, M

Olivieri, A

Valagussa, P

Farina, L

Milani, R

Scime, R

Rambaldi, A

Bonifazi, F

Patriarca, F

Locasciulli, A

Bacigalupo, A

Gianni, A

Tarella, C

机构：

[1] Ist Nazl Tumori, I-20133 Milan, Italy

[2] Ist San Raffaele, Milan, Italy

[3] Univ Ancona, Ancona, Italy

[4] Opsed Cervello, Palermo, Italy

[5] Osped Riuniti Bergamo, I-24100 Bergamo, Italy

[6] Osped St Orsola, Bologna, Italy

[7] Univ Udine, I-33100 Udine, Italy

[8] Osped San Camillo, Rome, Italy

[9] Osped San Martino Genova, Genoa, Italy

[10] Univ Turin, Turin, Italy

来源：

BONE MARROW TRANSPLANTATION | 2006年 / 37卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S47 / S47

页数：1

共 50 条

[31] Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Non-Hodgkin Lymphoma Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation [J].

Pollack, Seth M. ;

Steinberg, Seth M. ;

Odom, Jeanne ;

Dean, Robert M. ;

Fowler, Daniel H. ;

Bishop, Michael R. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) :223-230

[32] Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma [J].

Morris, E ;

Thomson, K ;

Craddock, C ;

Mahendra, P ;

Milligan, D ;

Cook, G ;

Smith, GM ;

Parker, A ;

Schey, S ;

Chopra, R ;

Hatton, C ;

Tighe, J ;

Hunter, A ;

Peggs, K ;

Linch, D ;

Goldstone, A ;

Mackinnon, S .

BLOOD, 2004, 104 (13) :3865-3871

[33] Reduced-intensity conditioning allogeneic stem cell transplantaion (RIST) for non-Hodgkin's lymphoma (NHL): A feasible treatment option. [J].

Kusumi, E ;

Tanimoto, TE ;

Kami, M ;

Miyakoshi, S ;

Hamaki, T ;

Kim, SW ;

Yuji, K ;

Tanosaki, R ;

Ueyama, J ;

Mineishi, S ;

Morinaga, S ;

Takaue, Y ;

Muto, Y .

BLOOD, 2002, 100 (11) :427A-428A

[34] Reduced-intensity allogeneic haematopoietic stem cell transplantation for lymphomas [J].

Bonifazi, F. ;

Colaci, E. ;

Bandini, G. ;

Arpinati, M. ;

Stanzani, M. ;

Usai, S. ;

Tazzari, P. ;

Bontadini, A. ;

Ricci, F. ;

Dan, E. ;

Taioli, S. ;

Fina, M. P. ;

Pellegrini, C. ;

Zinzani, P. ;

Baccarani, M. .

BONE MARROW TRANSPLANTATION, 2009, 43 :S216-S217

[35] ALLOGENEIC STEM CELL TRANSPLANTATION WITH REDUCED INTENSITY CONDITIONING REGIMEN IN PATIENTS WITH RELAPSED HODGKIN'S LYMPHOMA [J].

Marta Rivas, M. ;

Berro, M. ;

Virginia Prates, M. ;

Yantorno, S. ;

Milone, J. ;

Lisa Basquiera, A. ;

Adriana, B. ;

Jose Garcia, J. ;

Remaggi, G. ;

Martinez Rolon, J. ;

Burgos, R. ;

Foncuberta, C. ;

Feldman, L. ;

Jaimovich, G. ;

Real, J. ;

Milovic, V. ;

Arberbide, J. ;

Makiya, M. ;

Dibar, E. ;

Kusminsky, G. .

BONE MARROW TRANSPLANTATION, 2014, 49 :S172-S173

[36] Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin's Lymphoma [J].

Rivas, Maria Marta ;

Berro, Mariano ;

Yantorno, Sebastian ;

Prates, Maria Virginia ;

Milone, Jorge H. ;

Basquiera, Ana Lisa ;

Berreta, Adriana ;

Garcia, Juan ;

Remaggi, Guillermina ;

Rolon, Juliana Martinez ;

Arbelbide, Jorge ;

Makiya, Monica ;

Dibar, Eduardo ;

Requejo, Alejandro ;

Feldman, Leonardo Julio, Sr. ;

Milovic, Vera ;

Foncuberta, Maria Cecilia ;

Burgos, Ruben ;

Kusminsky, Gustavo Daniel .

BLOOD, 2013, 122 (21)

[37] Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells [J].

Corradini, P ;

Dodero, A ;

Zallio, F ;

Caracciolo, D ;

Casini, M ;

Bregni, M ;

Narni, F ;

Patriarca, F ;

Boccadoro, M ;

Benedetti, F ;

Rambaldi, A ;

Gianni, AM ;

Tarella, C .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2172-2176

[38] Autologous hematopoietic stem cell transplantation in non-Hodgkin's lymphomas [J].

Zinzani, PL .

ACTA HAEMATOLOGICA, 2005, 114 (04) :255-259

[39] Role of hematopoietic stem cell transplantation for relapsed or refractory pediatric non-Hodgkin lymphomas [J].

Pillon, M. ;

Prete, A. ;

Rondelli, R. ;

Carraro, E. ;

Zecca, M. ;

Messina, C. ;

Fagioli, F. ;

Lanino, E. ;

Rovelli, A. ;

Favre, C. ;

Caselli, D. ;

Ripaldi, M. ;

Locatelli, F. ;

Rosolen, A. .

BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 :41-41

[40] Reduced intensity allogeneic stem cell transplantation for relapsed Hodgkin and non-Hodgkin lymphoma lowers regimen toxicity and facilitates a graft-versus-lymphoma effect [J].

Mackinnon, S .

ANNALS OF ONCOLOGY, 2005, 16 :34-34

← 1 2 3 4 5 →